The role of IL-33/ST2 in COPD and its future as an antibody therapy

L Riera-Martínez, L Cànaves-Gómez, A Iglesias… - International journal of …, 2023 - mdpi.com
COPD is a leading cause of mortality and morbidity worldwide and is associated with a high
socioeconomic burden. Current treatment includes the use of inhaled corticosteroids and …

The emerging clinical significance of the red cell distribution width as a biomarker in chronic obstructive pulmonary disease: a systematic review

A Zinellu, AA Mangoni - Journal of Clinical Medicine, 2022 - mdpi.com
There is an intense focus on the identification of novel biomarkers of chronic obstructive
pulmonary disease (COPD) to enhance clinical decisions in patients with stable disease and …

The emerging role of macrophages in chronic obstructive pulmonary disease: the potential impact of oxidative stress and extracellular vesicle on macrophage …

M Finicelli, FA Digilio, U Galderisi, G Peluso - Antioxidants, 2022 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is one of the most common airway diseases,
and it is considered a major global health problem. Macrophages are the most …

Camellia sinensis L. Alleviates Pulmonary Inflammation Induced by Porcine Pancreas Elastase and Cigarette Smoke Extract

DU Shin, JE Eom, HJ Song, SY Jung, TV Nguyen… - Antioxidants, 2022 - mdpi.com
Cigarette smoke (CS) is the major factor in the development of chronic obstructive
pulmonary disease (COPD), the third leading cause of death worldwide. Furthermore …

[HTML][HTML] ДВОЙНАЯ БРОНХОЛИТИЧЕСКАЯ КОМБИНАЦИЯ УМЕКЛИДИНИЯ/ВИЛАНТЕРОЛА В ТЕРАПИИ ХОБЛ: ВОПРОСЫ ЭФФЕКТИВНОСТИ И …

НП Княжеская, ЭХ Анаев, АС Белевский… - Медицинский …, 2022 - cyberleninka.ru
Хроническая обструктивная болезнь легких (ХОБЛ)-заболевание, характеризующееся
ограничением скорости воздушного потока, которое обратимо не полностью, обычно …